Position in SANA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,251,353
+$546,651 QoQ
Shares Held
645,087
+9.0% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. SANA ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,251,353 | 645,087 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $1,704,702 | 591,911 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,288,608 | 562,312 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,928,760 | 543,313 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,452,719 | 532,132 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,119,537 | 666,392 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $578,160 | 354,700 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $1,776,789 | 427,113 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $2,520,405 | 461,613 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $4,350,400 | 435,040 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $865,587 | 212,154 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,851,724 | 478,482 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $2,801,640 | 470,074 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,664,559 | 509,040 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,922,969 | 486,828 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,873,664 | 478,944 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,593,700 | 403,375 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $1,490,524 | 180,451 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,929,766 | 124,662 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,740,436 | 121,689 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $333,944 | 16,986 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $512,325 | 15,307 | Shares | Defined | 2021-05-13 | |
| No filing history on record for this holder in this stock. | ||||||